Next Post

Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022

The following presentations will be made during the ESMO (European Society for Medical Oncology) Annual Meeting 2022, which will take place from September 9–13, 2022, in Paris, France, according to an announcement made today by Innate Pharma SA. 1. In a multi-center Phase Ib trial, lacutamab safety and efficacy in […]
thehealthco